Browsing Tag
AstraZeneca Pharma India Limited
2 posts
AstraZeneca Pharma India exits factory licence as #ASTRAZEN investors assess asset-light model
AstraZeneca Pharma India surrendered its factory licence as #ASTRAZEN exits manufacturing. Find out what the shift means for investors.
June 4, 2026
AstraZeneca Pharma India FY25 revenue jumps 32% to Rs 1,716cr on strong oncology growth
AstraZeneca Pharma India reports ₹1,716 Cr in FY25 revenue with 32% growth. Explore stock impact, new drug launches, and what’s next for pharma investors.
June 2, 2025